GlaxoSmithKline Faces Allegations in China

July 16 (Bloomberg) -- China is investigating at least four multinational drugmakers as it widens its probe of GlaxoSmithKline Plc, according to a lawyer in Hong Kong whose firm advises companies on cross-border anti-corruption. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)
May Take a Couple of Years to Turn Profitable: Snapdeal
31:57 - Snapdeal CEO and Co-Founder Kunal Bahl discusses India’s e-commerce industry, the companies that are interested in investing in his company, and his strategy for growth. He speaks to Bloomberg’s Shery Ahn at the Goldman Sachs TechNet Asia Conference in Hong Kong. (Source: Bloomberg)
  • How Micromax Is Tackling India's Smartphone Market
  • Tata Motors 4Q Profit Fell 56%
  • New Listings to Lock Up Billions in China